Dr. Lal PathLabs has informed that it enclosed a copy of the Certificate received from Link lntime India, the RTA (Registrars & Share Transfer Agent) of the Company, confirming the compliance under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2021.
The above information is a part of company’s filings submitted to BSE.